Arthritis drugs linked to cancer risk in major real-world study

A large national study found that JAK inhibitors and certain biological drugs used to treat rheumatoid arthritis and psoriatic arthritis carry measurable cancer risks. The findings could reshape treatment guidelines and force pharmaceutical companies and healthcare systems to reconsider how these widely prescribed medicines are deployed in clinical practice.

Originaltitel: Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study